Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 115
Chairperson
George J Weiner
Univ. of Iowa Holden Comp. Cancer Ctr., Iowa City, IA, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
William Foster
Independent Advocate, Gary, IN, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Andreana Natalie Holowatyj
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Invited Speaker
Brittany A. Avin
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 10:15 AM-12:15 PM
Keynote Speaker
Jill Biden
Biden Cancer Initiative, Washington, DC, United States
from AACR Annual Meeting 2019 on March 31, 2019 3:00 PM-4:45 PM
Panel 1 Discussion
Danielle Carnival
Biden Cancer Initiative, Washington, DC, United States
Adam Resnick
Children’s Hospital of Philadelphia, Philadelphia, PA, United States
Elizabeth Ann Shenkman
University of Florida College of Medicine, Gainesville, FL, United States
Maria Martinez
UC San Diego Moores Cancer Center, La Jolla, CA, United States
Jaime Guidry Auvil
National Cancer Institute, Bethesda, MD, United States
James W Lillard
Morehouse School of Medicine, Atlanta, GA, United States
from AACR Annual Meeting 2019 on March 31, 2019 3:00 PM-4:45 PM
Panel 2 Discussion
Gregory Simon
Biden Cancer Initiative, Washington, DC, United States
Justin Guinney
Sage Bionetworks, Seattle, WA, United States
Tatyana Kanzaveli
Open Health Network, Mountain View, CA, United States
Robert Grossman
University of Chicago, Chicago, IL, United States
Colin Hill
GNS Healthcare, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 31, 2019 3:00 PM-4:45 PM
Chairperson
Roy S Herbst
Yale Cancer Ctr., New Haven, CT, United States
from AACR Annual Meeting 2019 on April 1, 2019 3:00 PM-4:45 PM
Panelist
D'Jillisser Kelly
Learn to Grow, Atlanta, GA, United States
from AACR Annual Meeting 2019 on April 1, 2019 3:00 PM-4:45 PM
Invited Speaker
Brian A. King
Centers for Disease Control and Prevention, Atlanta, GA, United States
from AACR Annual Meeting 2019 on April 1, 2019 3:00 PM-4:45 PM
Invited Speaker
Mitchell Zeller
U.S. Food and Drug Administration, Rockville, MD, United States
from AACR Annual Meeting 2019 on April 1, 2019 3:00 PM-4:45 PM
Invited Speaker
Alison Cox
Cancer Research UK, London, United Kingdom
from AACR Annual Meeting 2019 on April 1, 2019 3:00 PM-4:45 PM
Chairperson
Anna R Giuliano
Moffitt Cancer Center, Tampa, FL, United States
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
Invited Speaker
Margaret A. Stanley
Univ. of Cambridge, United Kingdom
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
Invited Speaker
Mona Saraiya
CDC, Division of Cancer Prevention and Control, Atlanta, GA, United States
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
Invited Speaker
Marc Steben
Montreal, QC, Canada
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
Invited Speaker
Mark Jit
London School of Hygiene and Trpopical Medicine, London, United Kingdom
from AACR Annual Meeting 2019 on April 2, 2019 5:00 PM-6:30 PM
Biosimilar biologic products: The US FDA perspective
Joseph Franklin
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biologic complexity: Implications for biosimilar development
Simon Hotchin
Amgen, Inc., Thousand Oaks, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar development: Clinical implications and applications
Sara A Hurvitz
UCLA, Santa Monica, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar regulatory policy: Understanding the landscape and relevance to medical practice
Sue Lim
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Invited Speaker
Amy L. Rubinstein
National Institutes of Health, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 15, 2018 7:00 AM-8:00 AM
Invited Speaker
Daniel L. Gallahan
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 15, 2018 7:00 AM-8:00 AM
Chairperson
George D Demetri
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
Panelist
Kristin Anderson
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 25 of 115